AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 155 filers reported holding AMNEAL PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $523,280 | -90.6% | 124,000 | -95.5% | 0.00% | -90.9% |
| Q3 2022 | $5,555,000 | -49.6% | 2,750,000 | -20.6% | 0.02% | -52.2% |
| Q2 2022 | $11,018,000 | -11.9% | 3,464,900 | +15.5% | 0.05% | -8.0% |
| Q1 2022 | $12,505,000 | -21.2% | 2,998,880 | -9.4% | 0.05% | -20.6% |
| Q4 2021 | $15,862,000 | -20.7% | 3,311,400 | -11.6% | 0.06% | -28.4% |
| Q3 2021 | $19,998,000 | +114.0% | 3,745,000 | +105.2% | 0.09% | +109.5% |
| Q2 2021 | $9,343,000 | -52.7% | 1,824,804 | -37.8% | 0.04% | -54.3% |
| Q1 2021 | $19,732,000 | +572.5% | 2,931,900 | +189.8% | 0.09% | +411.1% |
| Q3 2019 | $2,934,000 | -87.7% | 1,011,800 | -69.5% | 0.02% | -85.5% |
| Q2 2019 | $23,772,000 | +33.9% | 3,315,460 | +314.4% | 0.12% | +69.9% |
| Q3 2018 | $17,752,000 | – | 800,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fosun International Ltd | 21,521,301 | $83,503,000 | 7.34% |
| Eversept Partners, LP | 2,656,208 | $10,306,087 | 2.29% |
| TPG Group Holdings (SBS) Advisors, Inc. | 16,213,367 | $62,908,000 | 1.13% |
| Prosight Management, LP | 512,659 | $1,989,000 | 0.95% |
| THB ASSET MANAGEMENT | 833,104 | $3,232,000 | 0.90% |
| GLOBEFLEX CAPITAL L P | 251,696 | $977,000 | 0.26% |
| XTX MARKETS LLC | 10,243 | $40,000 | 0.19% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 102,000 | $396,000 | 0.10% |
| PA Capital LLC | 33,874 | $132,000 | 0.09% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 60,900 | $236,000 | 0.07% |